- Home
- FTF vs ESPR Comparison
FTF vs ESPR Comparison
Compare FTF & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTF
- ESPR
- Stock Information
- Founded
- FTF 2003
- ESPR 2008
- Country
- FTF United States
- ESPR United States
- Employees
- FTF N/A
- ESPR N/A
- Industry
- FTF Finance/Investors Services
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- FTF Finance
- ESPR Health Care
- Exchange
- FTF Nasdaq
- ESPR Nasdaq
- Market Cap
- FTF 257.8M
- ESPR 208.1M
- IPO Year
- FTF N/A
- ESPR 2013
- Fundamental
- Price
- FTF $6.38
- ESPR $1.03
- Analyst Decision
- FTF
- ESPR Buy
- Analyst Count
- FTF 0
- ESPR 7
- Target Price
- FTF N/A
- ESPR $5.93
- AVG Volume (30 Days)
- FTF 153.9K
- ESPR 3.9M
- Earning Date
- FTF 01-01-0001
- ESPR 08-11-2025
- Dividend Yield
- FTF 11.45%
- ESPR N/A
- EPS Growth
- FTF N/A
- ESPR N/A
- EPS
- FTF N/A
- ESPR N/A
- Revenue
- FTF N/A
- ESPR $259,574,000.00
- Revenue This Year
- FTF N/A
- ESPR $4.07
- Revenue Next Year
- FTF N/A
- ESPR N/A
- P/E Ratio
- FTF N/A
- ESPR N/A
- Revenue Growth
- FTF N/A
- ESPR 12.99
- 52 Week Low
- FTF $5.76
- ESPR $0.69
- 52 Week High
- FTF $6.56
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- FTF 50.49
- ESPR 48.50
- Support Level
- FTF $6.33
- ESPR $0.99
- Resistance Level
- FTF $6.45
- ESPR $1.10
- Average True Range (ATR)
- FTF 0.05
- ESPR 0.07
- MACD
- FTF -0.01
- ESPR -0.01
- Stochastic Oscillator
- FTF 41.67
- ESPR 18.18
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.